Treating Type 2 Diabetes Mellitus: A Growing Epidemic
Author:
- Ruth S. WeinstockRWRuth S. Weinstock
- 1 April 2003
- journal article
- editorial
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 78 (4) , 411-413
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Insulin SensitizersMayo Clinic Proceedings, 2003
- Pharmacological Management of Type 2 Diabetes Mellitus: Rationale for Rational Use of InsulinMayo Clinic Proceedings, 2003
- Contributions of Insulin-Resistance and Insulin-Secretory Defects to the Pathogenesis of Type 2 Diabetes MellitusMayo Clinic Proceedings, 2003
- Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001JAMA, 2003
- Projection of Diabetes Burden Through 2050Diabetes Care, 2001
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38BMJ, 1998
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionNew England Journal of Medicine, 1998
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993